| Literature DB >> 29535919 |
Niloofar Yousefi Moteghaed1, Keivan Maghooli1, Masoud Garshasbi2.
Abstract
BACKGROUND: Gene expression data are characteristically high dimensional with a small sample size in contrast to the feature size and variability inherent in biological processes that contribute to difficulties in analysis. Selection of highly discriminative features decreases the computational cost and complexity of the classifier and improves its reliability for prediction of a new class of samples.Entities:
Keywords: Cancer classification; fuzzy support vector machine; gene expression; genetic algorithm; particle swarm optimization algorithm
Year: 2018 PMID: 29535919 PMCID: PMC5840891
Source DB: PubMed Journal: J Med Signals Sens ISSN: 2228-7477
Datasets which used for testing the efficiency of proposed method
Parameters in particle swarm optimization genetic algorithm
A sample chromosome of particle swarm optimization genetic algorithm/fuzzy support vector machine population
Figure 1Hybrid algorithm flowchart (particle swarm optimization/genetic algorithm/fuzzy support vector machine)
The results of applying hybrid (particle swarm optimization/genetic algorithm) to support vector machine classifier
The results of applying hybrid (particle swarm optimization/genetic algorithm) to fuzzy support vector machine classifier
Figure 2Occurrence frequency of genes by hybrid particle swarm optimization/genetic algorithm/fuzzy support vector machine algorithm with 10-fold cross validation. (a) Acute lymphoblastic leukemia, acute myeloid leukemia (b) acute lymphoblastic leukemia, mixed lineage leukemia (c) colon cancer (d) breast cancer
Figure 3Heatmaps on 4 cancer data show the differences behavior of genes in 2 classes of data. (a-d) the result for leukemia cancer in types acute lymphoblastic leukemia and mixed lineage leukemia, acute lymphoblastic leukemia and acute myeloid leukemia, colon, and breast cancer data, respectively
Extracted rules by decision tree on 4 cancer database
Summarizes results and comparison with literatures
Discovered biomarkers for leukemia and blood cancer (acute lymphoblastic leukemia, acute myeloid leukemia, mixed lineage leukemia)
Discovered biomarkers for colon and breast cancer by particle swarm optimization/genetic algorithm/fuzzy support vector machine